{"id":4752,"date":"2016-10-18T09:41:02","date_gmt":"2016-10-18T13:41:02","guid":{"rendered":"https:\/\/medicarereport.org\/?p=4752"},"modified":"2016-10-18T09:41:02","modified_gmt":"2016-10-18T13:41:02","slug":"medicare-part-d-a-first-look-at-prescription-drug-plans-in-2017","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=4752","title":{"rendered":"Medicare Part D: A First Look at Prescription Drug Plans in 2017"},"content":{"rendered":"<p>(By Jack Hoadley, Juliette Cubanski and Tricia Neuman for Kaiser Family Foundation published October 17, 2016)<\/p>\n<p>During the Medicare open enrollment period, which runs from October 15 to December 7 each year, beneficiaries can enroll in a plan that provides Part D drug coverage, either a stand-alone prescription drug plan (PDP) as a supplement to traditional Medicare, or a Medicare Advantage drug plan (MA-PD), which provides all Medicare-covered benefits including drugs. Of the nearly 41 million beneficiaries enrolled in Part D plans, about 6 in 10 are in PDPs and the rest in MA-PD plans.<a id=\"endnote_link_200728-1\" class=\"footnote-link\" title=\"These enrollment counts include nearly 7 million Part D enrollees in employer-only plans, not otherwise included in this analysis.\" href=\"http:\/\/kff.org\/medicare\/issue-brief\/medicare-part-d-a-first-look-at-prescription-drug-plans-in-2017\/view\/footnotes\/#footnote-200728-1\"><sup>1<\/sup><\/a> This issue brief provides an overview of the 2017 PDP marketplace,<a id=\"endnote_link_200728-2\" class=\"footnote-link\" title=\"For analysis of the 2016 Part D marketplace, see Jack Hoadley, Juliette Cubanski, and Tricia Neuman, \u201cMedicare Part D in 2016 and Trends over Time,\u201d Kaiser Family Foundation, September 2016, available at http:\/\/kff.org\/medicare\/report\/medicare-part-d-in-2016-and-trends-over-time\/.\" href=\"http:\/\/kff.org\/medicare\/issue-brief\/medicare-part-d-a-first-look-at-prescription-drug-plans-in-2017\/view\/footnotes\/#footnote-200728-2\"><sup>2<\/sup><\/a>\u00a0based on our analysis of data from the Centers for Medicare &amp; Medicaid Services (CMS).<a id=\"endnote_link_200728-3\" class=\"footnote-link\" title=\"Centers for Medicare &amp; Medicaid Services (CMS), \u201cMedicare Advantage Premiums Remain Stable; Enrollment at All-Time High,\u201d September 22, 2016; 2017 PDP, MA, and SNP Landscape Source Files and related files are available at http:\/\/www.cms.hhs.gov\/PrescriptionDrugCovGenIn\/.\" href=\"http:\/\/kff.org\/medicare\/issue-brief\/medicare-part-d-a-first-look-at-prescription-drug-plans-in-2017\/view\/footnotes\/#footnote-200728-3\"><sup>3<\/sup><\/a>\u00a0Key findings include: <a href=\"http:\/\/kff.org\/medicare\/issue-brief\/medicare-part-d-a-first-look-at-prescription-drug-plans-in-2017\/?utm_campaign=KFF-2016-October-Medicare-Part-D-Open-Enrollment&amp;utm_source=hs_email&amp;utm_medium=email&amp;utm_content=35954297&amp;_hsenc=p2ANqtz--EBANOrGpNghKPWWaQvcAf25RXG9f2KdFp1KyL3Ea2OYz3w-ui3jG6BX-OirwCk7B5lpKiiGRFwnT_UTCzKVpJ6LIzNg&amp;_hsmi=35954297\" target=\"_blank\">Continue reading findings here&#8230;&#8230;<\/a><\/p>\n<pre><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Jack Hoadley, Juliette Cubanski and Tricia Neuman for Kaiser Family Foundation published October 17, 2016) During the Medicare open<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6,9,15],"tags":[],"class_list":["post-4752","post","type-post","status-publish","format-standard","hentry","category-medicare-general","category-medicare-advantage","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4752","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4752"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4752\/revisions"}],"predecessor-version":[{"id":4753,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4752\/revisions\/4753"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4752"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4752"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4752"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}